3 Ph+ ALL was once considered the deadliest form of pediatric ALL, but addition of TKI therapy to intensive chemotherapy has improved cure rates substantially and obviated hematopoietic stem cell transplant (HSCT) in most cases.4, 5, 6 Nevertheless, still new findings emerge that change our ...
All patients signed an informed consent form for clinical trial participation, and all trials were approved by the institutional review board of The University of Texas MD Anderson Cancer Center. The eligibility criteria for these studies have been previously reported.16, 17, 18, 19 A total of ...